Institutions

There are many distinctions that set Phase I trials apart from the rest. For sites aiming for a successful Phase I trial, working with an organization that understands the nuances is key.

Messenger RNA (mRNA) has made recent headlines due to its role in Operation Warp Speed. This article explores how its technology is used to fight the COVID-19 pandemic.

Fiction often shows warp speed travels not going as planned, but what does warp speed mean for vaccine development in clinical research?

We strive to create meaningful and relevant content for the clinical research community. Check out our top resources of 2020.

Certificates of Confidentiality protect participant privacy by preventing disclosed sensitive information during research.

Learn more about the importance of medical coding dictionaries, their common uses, and best practices.

Coercion and undue influence in research can be complicated. Understand what these terms mean and how to appropriately protect against them.

Our experts answered some of the most popular questions from "Racial Diversity in Clinical Trials: Building Trust in Participant Engagement."

Checking the box is still an option on the FWA. At this time, institutions must carefully consider whether it makes sense to check the box.

On October 22, 2020, the FDA's VRBPAC met to discuss the development, authorization, and licensure of vaccines to prevent COVID-19.

Daniel Eisenman answers questions from his latest webinar Study Startup Success for the New Generation of Genetically Engineered Vaccines.

In investigator-initiated trials, an investigator takes on the clinical study as both the sponsor and investigator. Learn more about IITs impact on the clinical research industry.